Canada Pension Plan Investment Board’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
Other funds holding LGND
VPM
VCM
NAMI
CC
Canada Pension Plan Investment Board's LGND Position: Q1 2026 in Review
Canada Pension Plan Investment Board sold out of Ligand Pharmaceuticals (LGND) in Q1 2026, closing a stake of 1,600 shares — an estimated $303K sold.
Canada Pension Plan Investment Board first reported a position in LGND in Q1 2014 and held it in 16 quarters. The position peaked at $12M in Q4 2018. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.
- Canada Pension Plan Investment Board reported no remaining Ligand Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- Canada Pension Plan Investment Board sold 1,600 Ligand Pharmaceuticals shares in Q1 2026, an estimated $303K.
- Canada Pension Plan Investment Board first reported a position in Ligand Pharmaceuticals in Q1 2014 and held it in 16 quarters.
- Canada Pension Plan Investment Board's Ligand Pharmaceuticals position peaked at $12M in Q4 2018.
- 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.
Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.